0001628280-18-012395 Sample Contracts

October 4, 2018 Opiant Pharmaceuticals, Inc. Attn: Dr. Roger Crystal, Chief Executive Officer
Separation Agreement and General Release • October 9th, 2018 • Pollack Kevin • Metal mining
View Source